UD CIAN 450

Each sustained release uncoated tablet contains: Ursodeoxycholic acid IP 450 mg Excipients q.s.

DRUGHEPATO PROTECTIVE
CompositionEach sustained release uncoated tablet contains: Ursodeoxycholic acid IP 450 mg Excipients q.s.
PackingALU ALU - 10*10
MRP₹750

Product Overview

UD CIAN 450 is a high-strength, sustained-release therapeutic formulation of Ursodeoxycholic Acid (UDCA). Designed for optimal patient compliance, this once-daily tablet provides sustained levels of hydrophilic bile acids to manage advanced cholestatic liver conditions and facilitate gallstone dissolution. It protects liver tissue from cytotoxic damage and improves overall hepatic function parameters.

Indications

UD CIAN 450 is indicated for:

  • Primary Biliary Cirrhosis/Cholangitis: Long-term management of chronic cholestatic conditions.
  • Large Cholesterol Gallstones: Dissolution of radiolucent, non-calcified gallstones in symptomatic patients.
  • Biliary Sludge Prophylaxis: Prevents stone formation during rapid weight loss periods or bariatric surgery.

Dosage & Administration

The recommended dosage is one 450mg sustained-release tablet daily, taken at night with food, or as directed by a specialist. The tablet must be swallowed whole to preserve its sustained-release structural characteristics.

Adverse Effects

Common adverse effects include:

  • Diarrhea or loose stools
  • Abdominal discomfort or pain
  • Pruritus (temporary worsening)
View Complete Medical Information

Contraindications

Contraindicated in patients presenting with a non-functioning gallbladder, calcified gallstones, acute cholecystitis, biliary tract obstruction, or known allergy to bile acids.

Warnings & Precautions

Regular monitoring of liver function indices is required. Gallbladder imaging (ultrasound or cholecystography) should be conducted every 6 months to evaluate stone dissolution progress.

Drug Interactions

Avoid concurrent administration with antacids containing aluminum or magnesium, as they bind UDCA and lower efficacy. Clofibrate and oral contraceptives may increase gallstone formation risks, diminishing the drug's activity.

Storage Instructions

Store below 25°C in a clean, dry area away from direct sunlight and environmental moisture.

Product image not available

PCD Franchise Opportunity

Request This Product

  • WHO-GMP Certified Formulations
  • Monopoly Rights Available
  • Get bulk pricing & MOQ
Enquire NowWhatsApp Us Now

+91 9689237122 · replies within hours

Interested in this product?

Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.

Need something? Chat with us!